Myria Biosciences AG
Steven Schmitt is a CEO and Cofounder at Myria Biosciences since December 2021. Previously, Steven held various roles at ETH Zürich, including BRIDGE Fellow, Pioneer Fellow, and Postdoctoral Researcher. Steven also co-founded SpheroBiotics and worked as an Information Technology Consultant at SComp. Steven has a Doctor of Philosophy in Biotechnology from ETH Zürich and diplomas in Biology (Chemistry, BA) from The University of Queensland and Johannes Gutenberg University Mainz.
This person is not in any teams
Myria Biosciences AG
Myria Biosciences pioneers GEMMS (Genetically Engineered Modular Molecule Scaffolds), a new class of therapeutic molecules that combines the most important features of small molecules and biologics, the two work horses of the pharmaceutical industry, into one. Myria’s platform uses computational data mining, synthetic biology and high-throughput experimentation to design, produce and test millions of novel molecules, and provides innovative drug candidates for diseases where other drugs have failed to deliver.